Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5872-08-2

Post Buying Request

5872-08-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5872-08-2 Usage

Overview

DL-Camphorsulfonic acid, also known as camphorsulfonic acid, is a white or almost white crystalline powder. The molecular formula of camphorsulfonic acid is C10H16O4S. It is a pair of chiral optical enantiomers with prismatic crystals, divided into left-handed camphorsulfonic acid and right-handed camphorsulfonic acid. The melting point is 193~195 ℃ and 197~200 ℃, respectively. Camphorsulfonic acid is a derivative of camphor, widely used in medicine, light industry and cosmetic industry. At present, its application mainly focused on chiral asymmetric synthesis, high selective catalysis of natural products and polymer doping with polyaniline to prepare nano-scale conductive polymer materials. Figure 1: left-right isomer of camphorsulfonic acid

Preparation

natural camphor is mainly extracted from camphor plants, ginger plants and sage seeds, and with optical activity; synthetic camphor is generally prepared by the isomerization of turpentine to obtain camphene, then by esterification, hydrolysis and dehydrogenation reaction process; synthetic camphor is racemic, almost lacking optical activity. Through the reaction of camphor powder and concentrated sulfuric acid sulfonation, racemic camphorsulfonic acid is obtained, and then by the resolution, left and right handed camphorsulfonic acid is made. The optimum conditions for the synthesis of camphorsulfonic acid are as follows: the molar ratio of camphor powder, concentrated sulfuric acid and acetic anhydride is 1.0: 1.4: 3.0; reaction temperature is10 ℃; standing time is 5 days, and camphorsulfonic acid is vacuum dried. Utilizing sopropyl alcohol as solvent, camphor sulfonate is obtained by neutralization of camphorsulfonic acid and a resolving agent made by alcohol amine; camphorsulfonic acid is obtained by purification. Figure 2: Preparation principle

Resolution

Kinetic resolution is the selective chiral reduction of racemic camphor, so that one of the enantiomers of racemates is selectively reducted, leaving the required isomers, and then purifying. It is also possible to add optically active amino acids, phenylglycine, phenylalanine, hydroxyphenylglycine, o-chlorophenylglycine and resolving agents of its derivatives. Subjecting racemic camphorsulfonic acid to salting treatment, separating the left and right camphorsulfonic acid ammonium salt solution by chromatography, film evaporation, crystallization and filtration; drying to get white crystals, the left and right handed camphorsulfonic acid is made.

Uses

Different sources of media describe the Uses of 5872-08-2 differently. You can refer to the following data:
1. Pharmaceutical intermediates, optical split agent. Camphorsulfonic acid is an important organic synthesis intermediates, optical resolving agent. Due to its optical rotation, it is industrially applicable be the optical isomers for racemisation, and is also widely used as pharmaceutical intermediates such as for the production of intestinal disorder inhibitors, HIV improving agents and the like. Left and right handed camphorsulfonic acid is an important resolving agent for optically active amino acids, such as camphorsulfonic acid—a chiral ion-pairing reagent. It separates 5 substances—phenylpropanolamine, which has receptor-blocking action and cardiac inhibition and local anesthetic action effects; metoprolol, propranolol, epinephrine, salbutamol and atenolol. Camphor sulfonate made by camphorsulfonic acid for salting or other synthetic routes also has a wide range of uses. For example, camphor sulfonate is a veterinary central stimulant, which can stimulate the respiratory center and cause respiratory excitement, ; it is used for the treatment respiratory and circulatory acute disorders, resisting central nervous system poisoning; camphor ammonium sulfonate acts as a chiral ion pair reagent added to the mobile phase to separate the aromatic alcohol amine drug enantiomers. Figure 3: Camphor sulfonate
2. (+)-Camphor-10-sulfonic acid is used as a resolving agent for chiral amines and other cations. It is involved in the preparation of active pharmaceutical ingredient such as trimetaphan camsilate, which is used to reduce bleeding during neurosurgery. Further, it is involved in the transglucosidation of methyl and ethyl D-glucopyranosides by alcoholysis.

Market

The domestic demand for camphorsulfonic acid is high; camphorsulfonic acid is basically dependent on imports, and the price of it is also very expensive, especially for L-camphorsulfonic acid.

References

[1] KE Chunlan, LIU Xiaohong, XU Chunxiao etc. Synthesis and Resolution of Camphor Sulfonic Acid [J]. Journal of Nanchang University Engineering, 2010, 32 (4): 381-384. [2] KE Chunlan, LIU Xiaohong, XU Chunxiao etc. Synthesis and latest application of chiral camphorsulfonic acid and its salts [J] .Jiangxi Chemical Industry, 2010 (2): 1-4.

Chemical Properties

DL-10-CAMPHORSULFONIC ACID is white to off-white powder

General Description

Camphorsulfonic acid is a organosulphur compound.

Check Digit Verification of cas no

The CAS Registry Mumber 5872-08-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,8,7 and 2 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5872-08:
(6*5)+(5*8)+(4*7)+(3*2)+(2*0)+(1*8)=112
112 % 10 = 2
So 5872-08-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H16O4S/c1-9(2)7-3-4-10(9,8(11)5-7)6-15(12,13)14/h7H,3-6H2,1-2H3,(H,12,13,14)

5872-08-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C0016)  (±)-10-Camphorsulfonic Acid  >98.0%(T)

  • 5872-08-2

  • 25g

  • 180.00CNY

  • Detail
  • TCI America

  • (C0016)  (±)-10-Camphorsulfonic Acid  >98.0%(T)

  • 5872-08-2

  • 100g

  • 490.00CNY

  • Detail
  • TCI America

  • (C0016)  (±)-10-Camphorsulfonic Acid  >98.0%(T)

  • 5872-08-2

  • 500g

  • 1,290.00CNY

  • Detail
  • Alfa Aesar

  • (A12620)  (±)-Camphor-10-sulfonic acid, 98%   

  • 5872-08-2

  • 100g

  • 371.0CNY

  • Detail
  • Alfa Aesar

  • (A12620)  (±)-Camphor-10-sulfonic acid, 98%   

  • 5872-08-2

  • 500g

  • 1482.0CNY

  • Detail
  • Alfa Aesar

  • (A12620)  (±)-Camphor-10-sulfonic acid, 98%   

  • 5872-08-2

  • 2500g

  • 6691.0CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001397)  VoriconazoleimpurityE  European Pharmacopoeia (EP) Reference Standard

  • 5872-08-2

  • Y0001397

  • 1,880.19CNY

  • Detail
  • USP

  • (1718063)  VoriconazoleRelatedCompoundF  United States Pharmacopeia (USP) Reference Standard

  • 5872-08-2

  • 1718063-50MG

  • 14,500.98CNY

  • Detail
  • Aldrich

  • (147923)  Camphor-10-sulfonicacid(β)  98%

  • 5872-08-2

  • 147923-100G

  • 508.95CNY

  • Detail
  • Aldrich

  • (147923)  Camphor-10-sulfonicacid(β)  98%

  • 5872-08-2

  • 147923-500G

  • 1,956.24CNY

  • Detail

5872-08-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name DL-10-Camphorsulfonic Acid

1.2 Other means of identification

Product number -
Other names Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (±)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5872-08-2 SDS

5872-08-2Synthetic route

Camphor
76-22-2

Camphor

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

Conditions
ConditionsYield
With sulfuric acid; acetic anhydride
(1R,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one
464-49-3

(1R,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

Conditions
ConditionsYield
With sulfuric acid; acetic anhydride Reychler method;
dl-camphor

dl-camphor

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

Conditions
ConditionsYield
With sulfuric acid; acetic anhydride
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

bis-[(trifluoroacetoxy)iodo]benzene
2712-78-9

bis-[(trifluoroacetoxy)iodo]benzene

[di((camphorsulfonyl)oxy)iodo]benzene

[di((camphorsulfonyl)oxy)iodo]benzene

Conditions
ConditionsYield
In acetonitrile at 20℃; for 3h; Inert atmosphere;98%
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

(2,2,3-Trimethyl-cyclopent-3-enyl)-acetic acid
25435-53-4

(2,2,3-Trimethyl-cyclopent-3-enyl)-acetic acid

Conditions
ConditionsYield
With potassium hydroxide at 200 - 220℃; for 0.0833333h; Retro-Prins fragmentation;90%
Trimethyl orthoacetate
1445-45-0

Trimethyl orthoacetate

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

(+/-)-2-oxo-bornane-10-sulfonic acid methyl ester
46471-67-4, 62319-13-5, 83603-04-7

(+/-)-2-oxo-bornane-10-sulfonic acid methyl ester

Conditions
ConditionsYield
In dichloromethane at 20℃;89%
In dichloromethane at 20℃;89%
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

alfuzosin
81403-80-7

alfuzosin

N1-(4-amino-6,7-dimethoxyquinazol-2-yl)-N1-methyl-N2-(tetrahydrofuro-2-yl)propylenediamine (7,7-dimethyl-2-oxo-bicyclo[2,2,1]hept-1-yl)methanesulfonate

N1-(4-amino-6,7-dimethoxyquinazol-2-yl)-N1-methyl-N2-(tetrahydrofuro-2-yl)propylenediamine (7,7-dimethyl-2-oxo-bicyclo[2,2,1]hept-1-yl)methanesulfonate

Conditions
ConditionsYield
In ethyl acetate at 20 - 50℃; Product distribution / selectivity; Inert atmosphere;88%
2-(tetrahydro-2H-pyran-2-yl)-N-(3-(9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)pyridin-2-yl)-2H-indazol-4-amine
1253568-74-9

2-(tetrahydro-2H-pyran-2-yl)-N-(3-(9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)pyridin-2-yl)-2H-indazol-4-amine

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

N-(3-(9H-purin-6-yl)pyridin-2-yl)-1H-indazol-4-amine (+/-)-10-camphorsulfonate

N-(3-(9H-purin-6-yl)pyridin-2-yl)-1H-indazol-4-amine (+/-)-10-camphorsulfonate

Conditions
ConditionsYield
In methanol; dichloromethane at 40℃; for 22h;86%
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonyl chloride
6994-93-0

((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonyl chloride

Conditions
ConditionsYield
With thionyl chloride In N,N-dimethyl-formamide at 0 - 20℃; for 4.5h;85%
With trichloroacetonitrile; triphenylphosphine In dichloromethane for 1h; Heating;
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

alfuzosin hydrochloride
81403-68-1

alfuzosin hydrochloride

N1-(4-amino-6,7-dimethoxyquinazol-2-yl)-N1-methyl-N2-(tetrahydrofuro-2-yl)propylenediamine (7,7-dimethyl-2-oxo-bicyclo[2,2,1]hept-1-yl)methanesulfonate

N1-(4-amino-6,7-dimethoxyquinazol-2-yl)-N1-methyl-N2-(tetrahydrofuro-2-yl)propylenediamine (7,7-dimethyl-2-oxo-bicyclo[2,2,1]hept-1-yl)methanesulfonate

Conditions
ConditionsYield
Stage #1: alfuzosin hydrochloride With sodium hydroxide In dichloromethane; water
Stage #2: 10-camphorsufonic acid In dichloromethane at 20 - 40℃; Product distribution / selectivity;
84%
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

1,3,3-Trimethyl-5-nitro-2-{(E)-3-[1,3,3-trimethyl-5-nitro-1,3-dihydro-indol-(2E)-ylidene]-propenyl}-2,3-dihydro-1H-indol-2-ol

1,3,3-Trimethyl-5-nitro-2-{(E)-3-[1,3,3-trimethyl-5-nitro-1,3-dihydro-indol-(2E)-ylidene]-propenyl}-2,3-dihydro-1H-indol-2-ol

1,3,3,1',3',3'-Hexamethyl-5,5'-dinitroindocarbocyanine dl-10-camphorsulfonate

1,3,3,1',3',3'-Hexamethyl-5,5'-dinitroindocarbocyanine dl-10-camphorsulfonate

Conditions
ConditionsYield
With potassium hydroxide In methanol; water81%
9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl hydroxy(di-2-thienyl)acetate

9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl hydroxy(di-2-thienyl)acetate

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

C10H15O4S(1-)*C19H22NO4S2(1+)

C10H15O4S(1-)*C19H22NO4S2(1+)

Conditions
ConditionsYield
In dichloromethane; acetonitrile at 20℃; for 24h;80%
brucine
357-57-3

brucine

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

A

(1S)-10-camphorsulfonic acid
3144-16-9

(1S)-10-camphorsulfonic acid

B

(R)-10-camphorsulfonic acid
35963-20-3

(R)-10-camphorsulfonic acid

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

(1S)-10-camphorsulfonic acid
3144-16-9

(1S)-10-camphorsulfonic acid

Conditions
ConditionsYield
With brucine man zerlegt das ausscheideten Brucinsalz der -β-sulfonsaeure mit Barytwasser;
With brucine
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

(R)-10-camphorsulfonic acid
35963-20-3

(R)-10-camphorsulfonic acid

Conditions
ConditionsYield
With hydrogenchloride; d-phenylglycine
With brucine
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

Potassium; ((1S,4R)-7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-methanesulfonate
21791-95-7

Potassium; ((1S,4R)-7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-methanesulfonate

Conditions
ConditionsYield
With potassium hydroxide
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

C10H15PS4

C10H15PS4

Conditions
ConditionsYield
With tetraphosphorus decasulfide; tetra(n-butyl)ammonium hydroxide 2.) toluene, reflux, 16h; Yield given. Multistep reaction;
hydrogenchloride
7647-01-0

hydrogenchloride

(S)-2-phenylglycine
2935-35-5

(S)-2-phenylglycine

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

A

(1S)-10-camphorsulfonic acid
3144-16-9

(1S)-10-camphorsulfonic acid

B

(R)-10-camphorsulfonic acid
35963-20-3

(R)-10-camphorsulfonic acid

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

N-phenethyl-10-camphorsulfonamide

N-phenethyl-10-camphorsulfonamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Cl3CCN; PPh3 / CH2Cl2 / 1 h / Heating
2: 4-picoline / CH2Cl2 / 1 h / 20 °C
View Scheme
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

(+/-)-6-(camphor-10-sulfonamido)-hexanoic acid

(+/-)-6-(camphor-10-sulfonamido)-hexanoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 85 percent / SOCl2 / dimethylformamide / 4.5 h / 0 - 20 °C
2.1: MgO / H2O; dioxane / 0.25 h / Heating
2.2: 65 percent / H2O; dioxane / 16 h
View Scheme
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

(+/-)-6-(camphorquinone-10-sulfonamido)-hexanoic acid

(+/-)-6-(camphorquinone-10-sulfonamido)-hexanoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 85 percent / SOCl2 / dimethylformamide / 4.5 h / 0 - 20 °C
2.1: MgO / H2O; dioxane / 0.25 h / Heating
2.2: 65 percent / H2O; dioxane / 16 h
3.1: SeO2 / H2O; dioxane / 120 h / Heating
View Scheme
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: KOH
2: PBr3
3: xylene / Heating; Dallacker et al. method
View Scheme
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

(+)-10-bromo-2-chloro-2-nitrosocamphane

(+)-10-bromo-2-chloro-2-nitrosocamphane

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: KOH
2: PBr3
3: xylene / Heating; Dallacker et al. method
4: NH2OH-HCl
5: Cl2 gas / diethyl ether / 0 °C / Davidson method
View Scheme
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

10-bromocamphor oxime

10-bromocamphor oxime

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: KOH
2: PBr3
3: xylene / Heating; Dallacker et al. method
4: NH2OH-HCl
View Scheme
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

((1S,4R)-7,7-Dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-methanesulfonyl bromide

((1S,4R)-7,7-Dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-methanesulfonyl bromide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: KOH
2: PBr3
View Scheme
Ph(3-Cl)(5-OCHF2)-(R)CH(OH)C(O)-Aze-Pab(OMe)
433937-93-0

Ph(3-Cl)(5-OCHF2)-(R)CH(OH)C(O)-Aze-Pab(OMe)

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

C10H16O4S*C22H23ClF2N4O5

C10H16O4S*C22H23ClF2N4O5

4,4'-diformylbiphenyl
66-98-8

4,4'-diformylbiphenyl

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

C34H36O8S2(2-)*2Na(1+)

C34H36O8S2(2-)*2Na(1+)

Conditions
ConditionsYield
Stage #1: 10-camphorsufonic acid With sodium methylate In methanol; toluene at 25 - 66℃;
Stage #2: 4,4'-diformylbiphenyl In methanol; toluene at 66 - 70℃; for 7h;
2-methylspiro(1,3-oxathiolane-5,3'-quinuclidine)
124620-88-8

2-methylspiro(1,3-oxathiolane-5,3'-quinuclidine)

10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

cis-2-methylspiro(1,3-oxathiolane-5,3')quinuclidine camphorsulfonic acid salt

cis-2-methylspiro(1,3-oxathiolane-5,3')quinuclidine camphorsulfonic acid salt

Conditions
ConditionsYield
In methanol; toluene at 20℃; for 22h;12.04 g
10-camphorsufonic acid
5872-08-2

10-camphorsufonic acid

A

(1S)-10-camphorsulfonic acid
3144-16-9

(1S)-10-camphorsulfonic acid

B

(R)-10-camphorsulfonic acid
35963-20-3

(R)-10-camphorsulfonic acid

Conditions
ConditionsYield
With barium(II) perchlorate In methanol Solvent; Reagent/catalyst; Resolution of racemate;

5872-08-2Relevant articles and documents

Identification of small molecule sulfonic acids as ecto-5'-nucleotidase inhibitors

Raza, Rabia,Saeed, Aamer,Lecka, Joanna,Sévigny, Jean,Iqbal, Jamshed

, p. 1133 - 1139 (2013/01/15)

Ecto-5'-Nucleotidase inhibitors have great potential as anti-tumor agents. We have investigated biochemical properties of human and rat ecto-5'-Nucleotidases and characterized 19 small molecule sulfonic acid derivatives as potential inhibitors of ecto-5'-Nucleotidases. We identified 11 potent inhibitors of human and rat ecto-5'-Nucleotidases and checked their selectivity. Compound 10 (Sodium 2,4-dinitrobenzenesulfonate) with Ki value of 0.66 μM and 19 (N-(4- sulfamoylphenylcarbamothioyl) pivalamide) with Ki value of 0.78 μM were identified as the most potent inhibitors for human and rat ecto-5'-Nucleotidase, respectively. The present compounds have low molecular weights, water solubility and equal potency as compared to the reported inhibitors.

Dibenzonaphthyrones

-

, (2008/06/13)

Dibenzonaphthyrone of formula (I) wherein A1and A2independently of each other are unsubstituted or mono- to tetra-substituted o-C6-C18arylene, with the proviso that formula (I) does not represent a dibenzonaphthyrone of the formula The invention further relates to processes for the preparation thereof, to the use thereof for colouring/pigmenting high-molecular-weight organic material and to substance compositions comprising dibenzonaphthyrones.

Process for the preparation of D(-)αphenylglycine

-

, (2008/06/13)

The invention provides a process for the preparation of D(-)αphenylglycine by resolution of DLαphenylglycine by means of D(+)camphorsulfonic acid. The present process enables the preparation of D(-)αphenylglycine at a minimum loss of the very expensive starting materials, such as DLαphenylglycine and D(+)camphorsulfonic acid. The salts produced in this process are precipitated from the resolution filtrate and the filtrate may be discarded as effluent water without any danger to the environment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5872-08-2